mavilor2.5mg30tab

Mavilor 2.5 mg is a pharmaceutical product containing Letrozole, a potent non-steroidal aromatase inhibitor. It is primarily indicated for the treatment of hormone receptor-positive early breast cancer in postmenopausal women, as well as for extended adjuvant treatment of early breast cancer. By inhibiting the aromatase enzyme, it effectively reduces the production of estrogen in the body, which is essential for the growth of certain types of breast cancer cells. This medication should only be used under the strict supervision of an oncologist or a qualified healthcare professional.